These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 24703438)

  • 21. Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's).
    Lally L; Lebovics RS; Huang WT; Spiera RF
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1403-9. PubMed ID: 25299002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
    Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
    Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
    Cartin-Ceba R; Fervenza FC; Specks U
    Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Viviano L; Ding L; Sejismundo LP; Mieras K; Iklé D; Jepson B; Mueller M; Brunetta P; Allen NB; Fervenza FC; Geetha D; Keogh K; Kissin EY; Monach PA; Peikert T; Stegeman C; Ytterberg SR; Stone JH;
    Arthritis Rheum; 2013 Sep; 65(9):2441-9. PubMed ID: 23754238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
    Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C; Guillevin L
    Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
    De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
    Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients.
    Moog P; Probst M; Kuechle C; Hauser C; Heemann U; Thuermel K
    Scand J Rheumatol; 2014; 43(6):519-23. PubMed ID: 25179776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
    Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
    Reguiai Z; Tabary T; Maizières M; Bernard P
    J Am Acad Dermatol; 2012 Oct; 67(4):623-9. PubMed ID: 22261417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell-targeted therapy in systemic vasculitis.
    Lally L; Spiera R
    Curr Opin Rheumatol; 2016 Jan; 28(1):15-20. PubMed ID: 26599379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.